Benralizumab Market
Benralizumab Market Size, Share & Industry Analysis, By Source Synthetic Compound, Chemical Synthesis. By End-User (Pharmaceutical Industry, Healthcare & Hospitals, Medication & Research Institutions) and Forecast, 2025-2035.
The Benralizumab market is witnessing a CAGR of 5.5% during the forecast period of 2025-2035. Benralizumab, with the brand name Fasenra, is a monoclonal antibody against the interleukin-5 receptor alpha (IL-5Rα) on eosinophils that causes their accelerated depletion. As a result of this action, it is potent as an add-on maintenance in patients with severe eosinophilic asthma. The U.S. Food and Drug Administration approved benralizumab in November 2017 for use in patients with severe eosinophilic asthma.
In India, in December 2020, the Drug Controller General of India (DCGI) provided marketing authorization to benralizumab, having seen the drug’s possibility to treat the unmet medical needs of patients suffering from severe eosinophilic asthma. The drug can be used as a subcutaneous injection every eight weeks after a loading dose period.
The manufacture of benralizumab involves sophisticated biotechnological steps, such as recombinant DNA technology to produce the monoclonal antibody in mammalian cell cultures. Such steps are under strict regulatory control to ensure the safety, efficacy, and quality of the biologic drug. Regulatory bodies, including the FDA and DCGI, demand thorough data from clinical trials and manufacturing evaluations before approval for therapeutic application.
The addition of benralizumab to the treatment armamentarium provides a specific solution for the treatment of severe eosinophilic asthma, with the potential to decrease the need for oral corticosteroids and enhance patient outcomes. Its approval in different regions reflects the international acceptance of its clinical value and the dedication to making the latest treatment alternatives available for patients with severe asthma.
Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts
Report Scope & Segmentation
- Introduction
- Overview of Benralizumab.
- Key Applications & Industry Use Cases
- Market Scope & Study Objectives
- Market Overview
- Global Market Size & Growth Trends (Historical & Forecast)
- Market Value & Revenue Analysis
- Demand-Supply Dynamics
- Segmental Outlook
- By Source
- Synthetic Compound.
- Chemical Synthesis.
- Key End-Use Industries
- Pharmaceutical Industry.
- Healthcare & Hospitals.
- Research Institutions.
- Price Analysis
- Current Price Trends (Per kg & Per Ton)
- Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
- Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
- Production & Supply Volume
- Global Production Capacity & Key Manufacturers
- Production Process & Technological Developments
- Raw Material Analysis
- Trade Analysis (Import & Export)
- Major Exporting & Importing Countries
- Trade Volume & Value Statistics
- Impact of Trade Regulations & Policies
- Regional Analysis
- North America (US and Canada)
- Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
- Rest of the World (Latin America and Middle East and Africa)
- Competitive Landscape
- Top Global Manufacturers & Market Share
- Company Profiles & Key Developments
- Mergers, Acquisitions & Investments
- Regulatory & Compliance Factors
- FDA, REACH, and Other Regulatory Frameworks
- Environmental & Safety Considerations
- Emerging Policies Impacting Market Growth
- Conclusion & Strategic Recommendations
- Key Takeaways for Stakeholders
- Market Entry Strategies
- Frequently Asked Questions
- Choose License Type
$3600/- Multi User License
- Why Choose us?
- Experienced in market research and consulting.
- Seasoned professionals with diverse industry knowledge.
- Proven track record in delivering valuable insights.
- Tailored methodologies for unique client needs.
- End-to-end services: market analysis, competitor intelligence, consumer behavior, and strategic recommendations.
- Latest tools and tech for data collection, analysis, and visualization.
- Embrace of AI and machine learning for deeper insights.
- Global capabilities and extensive network.
- In-depth understanding of international markets, trends, and regulations.
- Dedicated to addressing specific client needs and goals.
- Focus on delivering value through efficient research outcomes.
- Recent posts
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
